ADVIL MIGRAINE - Haleon US Holdings LLC

Manufacturer
Haleon US Holdings LLC
Effective date
2026-07-29
Label type
HUMAN OTC DRUG LABEL
Version
15
Source
daily-update
Hydrated at
2026-08-01 05:10:11

Label at a glance#

ProductADVIL MIGRAINE
Active ingredientIBUPROFEN
Label structure10 sections

Dosage and administration

do not take more than directed the smallest effective dose should be used adults: take 2 capsules with a glass of water; if symptoms persist or worsen, ask your doctor; do not take more than 2 capsules in 24 hours, unless directed by a doctor under 18 years of age: ask a doctor

Label contents#

Full prescribing information#

Active ingredient (in each brown oval capsule)

OTC - ACTIVE INGREDIENT SECTION

Solubilized ibuprofen equal to 200 mg ibuprofen (NSAID)*

(present as the free acid and potassium salt)

*nonsteroidal anti-inflammatory drug

Purpose

OTC - PURPOSE SECTION

Pain reliever

Use

INDICATIONS & USAGE SECTION

  • treats migraine

Warnings

WARNINGS SECTION

Allergy alert:

SPL UNCLASSIFIED SECTION

Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

  • hives
  • facial swelling
  • asthma (wheezing)
  • shock
  • skin reddening
  • rash
  • blisters

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning:

SPL UNCLASSIFIED SECTION

This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you

  • are age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others]
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Heart attack and stroke warning:

SPL UNCLASSIFIED SECTION

NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Medication overuse headache warning:

SPL UNCLASSIFIED SECTION

Headaches may worsen if this product is used for 10 or more days per month.

Do not use

OTC - DO NOT USE SECTION

  • if you have ever had an allergic reaction to any other pain reliever/fever reducer
  • right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • you have never had migraines diagnosed by a health professional
  • you have a headache that is different from your usual migraines
  • you have the worst headache of your life
  • you have fever and stiff neck
  • you have headaches beginning after or caused by head injury, exertion, coughing or bending
  • you have experienced your first headache after the age of 50
  • you have daily headaches
  • you have a migraine so severe as to require bed rest
  • stomach bleeding warning applies to you
  • you have problems or serious side effects from taking pain relievers or fever reducers
  • you have a history of stomach problems, such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke
  • you are taking a diuretic

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • under a doctor's care for any serious condition
  • taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin
  • taking any other drug

When using this product

OTC - WHEN USING SECTION

  • take with food or milk if stomach upset occurs

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience any of the following signs of stomach bleeding:
    • feel faint
    • vomit blood
    • have bloody or black stools
    • have stomach pain that does not get better
  • you have symptoms of heart problems or stroke:
    • chest pain
    • trouble breathing
    • weakness in one part or side of body
    • slurred speech
    • leg swelling
  • migraine headache pain is not relieved or gets worse after the first dose
  • any new symptoms appear

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed
  • the smallest effective dose should be used
  • adults: take 2 capsules with a glass of water; if symptoms persist or worsen, ask your doctor; do not take more than 2 capsules in 24 hours, unless directed by a doctor
  • under 18 years of age: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • each capsule contains: potassium 20 mg
  • read all directions and warnings before use. Keep carton.
  • store at 20-25°C (68-77°F)
  • avoid excessive heat above 40°C (104°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

D&C yellow no. 10, FD&C green no. 3, FD&C red no. 40, gelatin, pharmaceutical ink, polyethylene glycol, potassium hydroxide, purified water, sorbitol sorbitan solution

Questions or Comments?

OTC - QUESTIONS SECTION

Call toll-free 1-800-88-ADVIL

Additional Information

SPL UNCLASSIFIED SECTION

READ AND KEEP CARTON FOR COMPLETEWARNINGS AND INFORMATION

Do Not Use if seal under bottle cap imprinted with “SEALED for YOUR PROTECTION” is broken or missing.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Advil
MIGRAINE

Solubilized Ibuprofen Capsules, 200 mg
Pain Reliever (NSAID)

Actual Size

20
Liquid Filled
Capsules

Advil Migraine 20 ct
Advil Migraine 20 ct

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1e73f975-1ce7-705e-2bcf-788b1b5e24baProduct name520251124
16cde546-8deb-4df2-a072-dab5566ede95Product name120231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015Product name420230808
874f4e63-49d2-5150-5d77-052172814ebdProduct name620230105
557673c2-8256-b351-e863-4ec71a5a64b0Product name220160714
dbc9a339-6215-4e94-9546-57a3b34902ceProduct name120160517
61c18d4e-b552-5478-8fc0-df38b93e3100Product name120140508
7b2938c9-7eb7-e312-ae90-f54f4240361eProduct name120140508
997601aa-bb5f-6971-6b90-a21132c12c7bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0573-0168-20EA - Each0573-0168feec2afc-1568-4618-bf50-6e30d394343812012-07-24
0573-0168-30EA - Each0573-0168f0189b18-316b-4562-a067-96974923eda812012-07-24
0573-0168-40EA - Each0573-01683d739668-e89f-4a57-9aa7-68e2a5a0dafa12014-06-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
IBUPROFENACTIVE INGREDIENTWK2XYI10QM4
IBUPROFENACTIVE MOIETYWK2XYI10QM4
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3G4
FD&C GREEN NO. 3INACTIVE INGREDIENT3P3ONR6O1S4
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOA4
GELATININACTIVE INGREDIENT2G86QN327L4
LIGHT MINERAL OILINACTIVE INGREDIENTN6K5787QVP4
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T4
SORBITANINACTIVE INGREDIENT6O92ICV9RU4
SORBITOLINACTIVE INGREDIENT506T60A25R4
WATERINACTIVE INGREDIENT059QF0KO0R4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0573-01680573-0168-20, 0573-0168-30, 0573-0168-40

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
142025-10-03full-release2026-06-01 01:15:53

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 120 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SORBITOLSORBITOL506T60A25RCONCENTRATE / ORAL600 mg/1mlExact identifier — unii+route
72 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPCAPSULE / ORAL6 mgExact identifier — unii+route
24 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii+route
72 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPCAPSULE / ORAL6 mgExact identifier — unii+route
24 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, COATED / ORAL12.96 mgExact identifier — unii+route
72 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE, LIQUID FILLED / ORAL154 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCONCENTRATE / ORAL600 mg/1mlExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, COATED / ORAL12.96 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSOLUTION, CONCENTRATE / ORAL300 mg/1mlExact identifier — unii+route
72 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE, LIQUID FILLED / ORAL154 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITANSORBITAN6O92ICV9RUCAPSULE, LIQUID FILLED / ORALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / ORAL45000 mgExact identifier — unii+route
72 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GCAPSULE, LIQUID FILLED / ORAL1.51 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCAPSULE / ORAL1111 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RELIXIR / ORAL833.3 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, FILM COATED / ORAL5 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RLIQUID / ORAL53460 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, EXTENDED RELEASE / ORAL428 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER / ORAL36000 mgExact identifier — unii+route
72 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACAPSULE, LIQUID FILLED / ORAL1 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, CHEWABLE / ORAL3555 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER / ORAL36000 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET / ORAL337.28 mgExact identifier — unii+route
72 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPTABLET, EXTENDED RELEASE / ORAL1 mgExact identifier — unii+route
24 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPCAPSULE / ORAL6 mgExact identifier — unii+route
24 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPPASTILLE / ORAL3.6 mgExact identifier — unii+route
24 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPTABLET, COATED / ORAL4.8 mgExact identifier — unii+route
24 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / ORAL45000 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RELIXIR / ORAL833.3 mgExact identifier — unii+route
72 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE, LIQUID FILLED / ORAL154 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPTABLET / ORAL7.5 mgExact identifier — unii+route
24 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCAPSULE / ORAL1111 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RGUM, CHEWING / ORAL6168 mgExact identifier — unii+route
72 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE, LIQUID FILLED / ORAL1042 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, CHEWABLE / ORAL3555 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER / ORAL36000 mgExact identifier — unii+route
72 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPPASTILLE / ORAL3.6 mgExact identifier — unii+route
24 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPPASTILLE / ORAL3.6 mgExact identifier — unii+route
24 equally ranked IID candidates
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPTABLET, COATED / ORAL4.8 mgExact identifier — unii+route
24 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSOLUTION, CONCENTRATE / ORAL300 mg/1mlExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RELIXIR / ORAL833.3 mgExact identifier — unii+route
72 equally ranked IID candidates
FD&C GREEN NO. 3FD&C GREEN NO. 33P3ONR6O1SCAPSULE, LIQUID FILLED / ORAL0.03 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RGUM, CHEWING / ORAL6168 mgExact identifier — unii+route
72 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GCAPSULE, LIQUID FILLED / ORAL1.51 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, FILM COATED / ORAL5 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSUSPENSION / ORAL45000 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, ORALLY DISINTEGRATING / ORAL7 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSYRUP / ORAL4370 mg/5mlExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RPOWDER, FOR SUSPENSION / ORAL12000 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, FILM COATED / ORAL5 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, CHEWABLE / ORAL3555 mgExact identifier — unii+route
72 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACAPSULE, LIQUID FILLED / ORAL1 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RSOLUTION / ORAL29268 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, EXTENDED RELEASE / ORAL428 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RGUM, CHEWING / ORAL6168 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITANSORBITAN6O92ICV9RUCAPSULE, LIQUID FILLED / ORALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACAPSULE, LIQUID FILLED / ORAL1 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
FD&C GREEN NO. 3FD&C GREEN NO. 33P3ONR6O1SCAPSULE, LIQUID FILLED / ORAL0.03 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RTABLET, COATED / ORAL12.96 mgExact identifier — unii+route
72 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCONCENTRATE / ORAL600 mg/1mlExact identifier — unii+route
72 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020402-001ADVIL LIQUI-GELSIBUPROFENEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20
N020402-002ADVIL MIGRAINE LIQUI-GELSIBUPROFENEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2084e616aacf4f…
2026-09-14 22:38:342026-08N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1684e616aacf4f…
2026-08-18 06:07:402026-07N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20caaa826d4ba7…
2026-08-18 06:07:402026-07N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-206a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-202680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-205bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20d06236e962d9…
2024-10-29 15:01 UTC2024-10N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-20301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-201e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-208072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-205c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-205d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-204b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-164b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020402-001ADVIL LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS1995-04-2074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020402-002ADVIL MIGRAINE LIQUI-GELSEQ 200MG FREE ACID AND POTASSIUM SALTCAPSULE / ORALRLD, RS2000-03-1674a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADVIL MIGRAINEIBUPROFENHaleon US Holdings LLCe4a6219d-4ad4-0119-4cf8-7fc39b4b59792026-07-29WarningsExact identifier
ndc (package): 0573-0168-20
ndc (package): 0573-0168-30
ndc (package): 0573-0168-40
ndc (product): 0573-0168
ndc11 (package): 00573016840
ndc11 (package): 00573016820
ndc11 (package): 00573016830
spl id: 57c53a9c-1065-d202-e063-6394a90ae1e4
spl set id: e4a6219d-4ad4-0119-4cf8-7fc39b4b5979

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.